ICH Guideline, Good Clinical Practice (GCP), E6(R3), DRAFT, 05/23 Anastasija Eschricht2023-07-24T13:11:24+00:00July 24th, 2023|
FDA GFI, Digital Health Technologies for Remote Data Acquisition in Clinical Investigations, DRAFT, 12/21 Anastasija Eschricht2023-06-27T11:50:00+00:00June 27th, 2023|
FDA GFI, Decentralized Clinical Trials for Drugs, Biological Products, and Devices, DRAFT, 05/23 Anastasija Eschricht2023-06-27T09:52:58+00:00June 27th, 2023|
FDA GFI, Generally Accepted Scientific Knowledge in Applications for Drug and Biological Products: Nonclinical Information, DRAFT, 05/23 Anastasija Eschricht2023-06-27T09:47:42+00:00June 27th, 2023|
FDA GFI, Formal Dispute Resolution and Administrative Hearings Under Section 505G of the F,D &C Act, DRAFT, 06/23 Anastasija Eschricht2023-06-27T09:12:25+00:00June 27th, 2023|
OECD Advisory Document: Quality Assurance and GLP, DRAFT, 09/21 Anastasija Eschricht2023-03-21T12:49:52+00:00March 21st, 2023|
